Allstate Corp Moderna, Inc. Transaction History

Allstate Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $21,190 - $37,597	179 Added 1.28%	14,190 $2.55 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $39,553 - $65,050	335 Added 2.45%	14,011 $1.66 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $543,717 - $819,730	-4,642 Reduced 25.34%	13,676 $1.95 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $1.07 Million - $1.98 Million	-8,422 Reduced 31.5%	18,318 $3.16 Million
Q4 2021 Feb 15, 2022	BUY	$225.82 - $368.51 $4.55 Million - $7.43 Million	20,163 Added 306.57%	26,740 $6.79 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $96,748 - $211,228	-436 Reduced 6.22%	6,577 $2.53 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $115,749 - $209,367	-891 Reduced 11.27%	7,013 $1.65 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $89,090 - $151,759	816 Added 11.51%	7,904 $1.04 Million
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $77,573 - $200,434	1,180 Added 19.97%	7,088 $740,000
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $95,475 - $166,651	1,757 Added 42.33%	5,908 $418,000
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $123,160 - $332,080	4,151 New	4,151 $267,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.